|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine显示文摘 | Vlahou A Schellhammer P F Mendrinos S | 2001 | Am J Pathol2001，158，4： | 1 |
| 2 | The effect of transurethral prostatic resection on the incidence of osseous prostatic metastasis 显示文摘 | Kuban D A el-Mahdi A M Schellhammer P F | 1985 | Cancer1985，56，4： | 1 |
| 3 | Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine 显示文摘 | Vlahou A Schellhammer P F Mendrinos S | 2001 | Am J Pathol2001，158，： | 1 |
| 4 | Integrated data from 2 randomized, double-bhnd, placebo-controlled, phase 3 trials of active cellular immunotherapy with tate cancer显示文摘 | Higano C S Schellhammer P F Small E J | 2009 | Cancer2009，115，16： | 1 |
| 5 | Pre- malignant lesions and nonsquamous malignancy of the penis and carcinoma of the scrotum显示文摘 | Schellhammer P F Jordan G H Robey E L | 1992 | Urol Clin North Am1992，19，1： | 1 |
| 6 | Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer显示文摘 | Sarosdy M F Schellhammer P Bokinsky G | 2002 | J Urol2002，168，5： | 1 |
| 7 | Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients显示文摘 | Qu Y Adam B L Yasui Y Ward M D Cazares L H Schellhammer P F | 2002 | Clin Chem2002，48，： | 1 |
| 8 | Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine 显示文摘 | VLAHOU A SCHELLHAMMER P F MENDRINOS S | 2001 | Am J Pathol2001，158，： | 1 |
| 9 | Placebo-controlledphase IE trial of immunologic therapy with sipuleucel-T ( APC8015)in patients with metastatic,asymptomatic hormone refractory prostatecancer显示文摘 | Small E J Schellhammer P F Higano C S | 2006 | Clin Oncol2006，24，： | 1 |
| 10 | Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘 | SMALL E J SCHELLHAMMER P F HIGANO C S | 2006 | J Clin Oncol2006，24，： | 1 |
| 11 | Integrated datafrom 2 randomized,double-blind,placebo-controlled,phase 3 trialsof active cellular immunotherapy with sipuleucel-T in advancedprostate cancer显示文摘 | Higano C S Schellhammer P F Small E J | 2010 | Cancer2010，115，： | 1 |
| 12 | Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis 显示文摘 | SCHELLHAMMER P F BEAN M A WHITMORE WF JR | 1977 | J Urol1977，118，3： | 1 |
| 13 | 0ral bropiriminc immunotherapy of carcinoma in situ of the bladder: results of a phase Ⅱ trial显示文摘 | Lowe B A Schellhammer P F | 1996 | Urology1996，48，： | 1 |
| 14 | Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of blad2 der cancer显示文摘 | Michael F Sarosdy M F Schellhammer P etal | 2002 | J Urol2002，268，5： | 1 |
| 15 | In- tegrated data from 2 randomized, double-blind: placebo-con- trolled, phase 3 trials of active cellular immunotherapy with sipulcucel-T in advanced prostate cancer显示文摘 | HIGANO C S SCHELLHAMMER P F SMALL E J | 2009 | Cancer2009，115，16： | 1 |
| 16 | Clinical evaluation of a multi target fluorescence in situ hybridization assay for detection of bladder cancer显示文摘 | Sarosdy M F Schellhammer P Bokinsky G | 2002 | J Urol2002，168，3： | 1 |
| 17 | Placebo- controlled phase III trial of immunologic therapy with sipuleucel-T(APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer 显示文摘 | Small E J Schellhammer P F Higano C S | 2006 | J Clin 0ncol2006，24，19： | 1 |
| 18 | Clinical e- valuation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer 显示文摘 | Michael F Sarosdy MF Schellhammer P | 2002 | J Urol2002，168，5： | 1 |
| 19 | Placebo- controlled phase III trial of immunologic therapy with sipuleu- cel-T (APC8015) in patients with metastatic, asymptomatichormone refractory prostate cancer显示文摘 | Small E J Schellhammer P F Higano C S | 2006 | J Clin Oncol2006，24，19： | 1 |
| 20 | Integrated data from 2 randomized, double-blind, placebo-controlled, phase 3 trims of active cellular immunotherapy with sipuleu- cel-T in advanced prostate cancer 显示文摘 | Higano C S Schellhammer P F Small E J | 2009 | Cancer2009，115，16： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员